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In mammography, breast compression is necessary and an important factor influencing 
image quality. The purpose of this study was to determine the influence of the menstrual 
cycle on compression-induced pain during mammography and to evaluate the association 
between the thickness and volume of the mammary gland and pain. We examined basal 
body temperature and categorized the menstrual cycle into five phases. We executed 
breast compression in the craniocaudal  view using a customized compression plate, to 
which we introduced an opening. We measured the thickness of the mammary gland under 
compression using echography. Immediately after releasing the compression, we 
evaluated pain using the visual analogue scale. We performed magnetic resonance 
imaging (MRI) on the same day and measured the volume of the mammary gland. The 
thickness of the mammary gland, pain, and the volume of the mammary gland were 
minimal in the late follicular phase and maximal in the late luteal and early follicular 
phases. It was shown that the changes in the thickness and volume of the mammary gland 
during the menstrual cycle accounted for the changes in compression-induced pain. On 
MRI examination of each breast quadrant, the same changes were observed in areas A 
and C. In area A, it was shown that both the anatomical characteristics and the increase 
in volume of the mammary gland were associated with pain. We concluded that the late 
follicular phase constitutes the optimal timing for mammography. 
 







The most common type of cancer affecting Japanese women is breast cancer, and it is 
believed that 1 in 11 Japanese women will be affected by breast cancer during their 
lifetime [1]. Breast cancer screening with mammography is standard in Japan; however, 
there is much hesitation about undergoing mammography because of fear of the pain 
associated with compression. Additionally, a feeling of turgescence and pain appears 
before menses; therefore, it is preferable to avoid performing mammography during that 
time.  
Vogal et al. classified the menstrual cycle into five phases: proliferative (days 3–7), 
follicular phase of differentiation (days 8–14), luteal phase of differentiation (days 15–
20), secretory (days 21–27), and menstrual (days 28–2) [2]. During the luteal phase, 
progesterone increases and the blood flow in microvessels also increases with a slight 
proliferation of epithelial cells in the mammary gland tissue. As a result, the interstitial 
connective tissue of the breasts becomes edematous. Feelings of turgescence and pain, 
therefore, appear before menses. At the end of menses, these changes reverse and the 
feeling of turgescence disappears [3].  
 Many studies have reported changes in breast imaging findings in accordance with the 
menstrual cycle [4-10]. Using magnetic resonance imaging (MRI), Kuhl et al. evaluated 
the contrast effect of mammary gland parenchyma according to the menstrual cycle and 
reported that the contrast effect is at the lowest level during the second week [6]. Delille 
et al. recommended that breast MRI be performed during the first half of the menstrual 
cycle (days 3–14) because gadolinium assimilation of normal breast tissue is minimum 
during this period [9]. Moreover, Amarosa et al. also proved that the contrast effect of 
mammary gland parenchyma and lesions change according to the phase of the menstrual 
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cycle [10]. On ultrasound, Onoda et al. compared the degree of strain of mammary gland 
parenchyma according to the menstrual cycle using elastography. They reported that there 
was no significant difference among the menstrual phases [11]. Wojcinski et al. reported 
that healthy volunteers showed elasticity with relatively soft breast parenchyma in the 
menstrual and follicular phases and harder parenchyma in the luteal phase [12]. There 
have been few studies, however, regarding changes in compression thickness of the breast 
parenchyma during mammography according to the phases of the menstrual cycle. The 
purpose of this study was to determine the influence of the menstrual cycle on 
compression-induced pain during mammography and to evaluate the association between 
the thickness and volume of the mammary gland and pain. 
 
Materials and methods 
The participants were women with abundant breast parenchyma, aged 22 ± 0.77 years 
old. They had no experience of pregnancy and childbirth. This study was approved by our 
Institutional Review Board (IRB), and informed consent was obtained from all 
participants. Eleven women were evaluated; one person dropped out after a unilateral 
mammography. Another person was not able to undergo the MRI examination due to 
orthodontic treatment. As a result, mammography was performed on 21 breasts and MRI 
was performed on 20 breasts. 
First, we monitored body temperature in the oral cavity as soon as possible after the 
women woke up from at least 4 h of sleep. Accordingly, we determined their menstrual 
cycle by determining the ovulation day based on when it changed from the high-
temperature phase to the low-temperature phase. We classified the menstrual cycle into 
the five phases shown in Table 1.  
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During mammography, we executed positioning in the craniocaudal (CC) view during 
each menstrual phase in each case. We used a commercially available device (MGU-
1000A; TOSHIBA, Tokyo, Japan) and our own compression plate, as described below. 
We pierced the compression plate such that the center was at a position 3.5 cm from the 
chest wall, the area through which an ultrasound probe was to be placed (Fig. 1). Because 
the participants were young, high breast tissue density was expected and since none of 
them had voluminous breasts, we set the position that would correspond to the largest 
volume of mammary gland to 3.5 cm, not 4 cm, from the chest wall. Positioning was 
executed by a radiological technologist who had received certification for mammography 
screening from The Japan Central Organization on Quality Assurance of Breast Cancer 
Screening. The breast was pressed using the customized compression plate until breast 
compression thickness remained unchanged. We started the measurement from Phase III 
of the menstrual cycle. We recorded the compression pressure applied during Phase III, 
and compression was performed using the same pressure in the remaining four phases. 
After pressing, we inserted a probe in the hole (Fig. 2) and imaged the echogram to 
specifically measure the thickness of breast parenchyma. A UIPS-640A instrument 
(TOSHIBA, Tokyo, Japan) equipped with a 7.5-MHz linear probe was used. We defined 
an area 2 cm inside from the center of the breast as the “inside”, and 2 cm outside as the 
“outside” . We measured the inside and outside thickness of the mammary gland (Fig. 3). 
We recorded positional relations of the hole and nipple in Phase III and the measurement 
was conducted in the same position in the remaining four phases. We calculated the 
thickness of the mammary gland in each menstrual phase.  
Measurement of pain was performed just after the positioning for mammography. We 
6 
 
used the visual analogue scale (VAS), defining the maximum value as 100 (Fig. 4). We 
also calculated the volume of the mammary gland using MRI. The MRI scan was 
performed by a radiological technologist on the same day as the positioning for 
mammography. We attached nifedipine (Adalat capsule, 5 mg; Bayer Yakuhin, Osaka, 
Japan) to the nipple, which demonstrated a high-intensity appearance on the image. All 
MRI examinations were performed using a MR-SW-150A 1.5-Tesla device (HITACHI, 
Tokyo, Japan). We acquired the fat-suppressed, T1-weighted image [repetition time/echo 
time (TR/TE),639/8 ms; a flip angle, 90°; number of signal averages (NSA), 3; matrix, 
320 × 320; field of view (FOV), 320 mm; slice thickness/gap, 4/5.8 mm; number of 
slices,36] in the prone position. We separated the breast into an upper and lower territory, 
with the nipples as anchoring points, and further separated it into the inside and outside 
territory, based on the line connecting the nipple and the midpoint between the two breast 
side walls (Fig. 5). Next, we calculated the volume of the mammary gland in each 
quadrant: areas A, B, C, and D. We calculated the mammary gland volume of each 
quadrant in each menstrual phase using the Sync Measure 3D plug-in for ImageJ 
(National Institutes of Health, Bethesda, MD, USA). The same radiological technologist 
performed the measurements in all participants for all five menstrual phases.  
The statistical analysis was performed using SPSS Statistics 22 (IBM, Chicago, IL, 
USA). Using Phase I as the base value, comparisons of the thickness of the mammary 
gland were analyzed using the paired t test. Measurement of pain between the groups was 
analyzed using the Tukey–Kramer test. Again, using Phase I as the base value, 
comparisons of the volume of the mammary gland were analyzed using the paired t test. 





We measured the thickness of the mammary gland, pain on compression during 
mammography, and the volume of the mammary gland using MRI for each participant 
during each menstrual phase. 
We calculated the thickness of the mammary gland in each menstrual phase (Table 2). 
Mammary gland thickness on the inside and outside was the thinnest during Phase III. 
There were significant differences between Phases I and II, Phases I and III, and Phases 
I and IV (Fig. 6a, b). The width of the standard deviation was widened due to individual 
differences in mammary gland thickness. Based on these results, it was shown that the 
thickness of the mammary gland was greatest during Phase I and it decreased until Phase 
III. After Phase III, it increased. 
Regarding the pain on compression, we calculated it using the VAS, defining the 
maximum value as 100. The averages of the VAS for each phase were 69.34 ± 19.86 for 
Phase I, 51.43 ± 18.75 for Phase II, 46.83 ± 16.47 for Phase III, 53.99 ± 16.92 for Phase 
IV, and 53.69 ± 21.65 for Phase V. Pain was minimal during Phase III, and there were 
significant differences between Phases I and II, and between Phases I and III (Fig. 7). 
Based on these results, it was shown that pain was at its maximum during Phase I, and it 
decreased until Phase III. After Phase III, it increased. 
Furthermore, regarding the MRI examination, we calculated the volume of the 
mammary gland in each quadrant. We calculated of the mammary gland volume of each 
quadrant in each menstrual phase (Table 3, Fig. 8). The width of the standard deviation 
was widened due to individual differences in mammary gland volume. The total volume 
of the mammary gland was most decreased during Phase III, and there were significant 
differences between Phases I and II, Phases I and III, and Phases I and IV. In areas A, 
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volume was most decreased during Phase III, and there were significant differences 
between Phases I and II, and between Phases I and III. In areas C, volume was most 
decreased during Phase III, and there were significant differences between Phases I and 
II, Phases I and III, and Phases I and IV. In area B, volume was most decreased during 
Phase II and there was a significant difference between Phases I and II. In area D, volume 
was most decreased during Phase IV, and there were significant differences between 
Phase I and all other phases.  
 
Discussion 
Although mammography is usually performed for breast cancer screening in Japan, 
many women forgo the examination to avoid experiencing compression-associated pain. 
As women may experience pain and turgescence prior to menses, it is preferable to 
perform mammography outside that time. 
There has been limited research regarding changes in compression thickness of the 
breast parenchyma during mammography, according to the phases of the menstrual cycle. 
Moreover, women undergoing mammography more frequently complain of stronger pain 
in the CC view than in the mediolateral-oblique view. We examined the influence of the 
menstrual cycle on mammary gland thickness in the CC view, because of avoidance of 
the stronger pain performing mammography. 
On both the inside and outside views, mammary gland thickness was greatest during 
Phase I. It decreased after day 4 of menses and it became lowest during Phase III. In Phase 
V, it increased to a value almost identical to that of Phase I. Pain in the CC positioning 
became strongest during Phase I, and it decreased after day 4 of menses, becoming 
weakest during Phase III. Subsequently, it became strong again after ovulation. It was 
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shown that the change in thickness of the mammary gland during the menstrual cycle 
accounted for the change in pain on compression.  
We measured the change in volume of the mammary gland during the menstrual cycle 
using MRI. The total volume was most increased during Phase I and most decreased 
during Phase III. After Phase III, it gradually increased. On examination of each quadrant, 
areas A and C showed a tendency similar to this. It was shown that the change in volume 
of the mammary gland during the menstrual cycle accounted for the change in pain on 
compression. However, in areas B and D, the volume decreased in all phases compared 
to that of Phase I. Area C was the quadrant most abundant in mammary gland tissue, 
followed by area A; therefore, it was supposed that changes in areas C and A reflected 
changes in the total volume of the mammary gland. Accordingly, the change of the inside 
mammary gland thickness on compression was attributable to area A, and the change of 
the outside mammary gland thickness was attributable to area C.  
It is believed that area A contributes more to the pain on compression than the other 
quadrants because it is fixed. From our results, it was shown that both the anatomical 
characteristics and the increase in volume of the mammary gland were involved in pain 
experienced in area A. It is an essential requirement that the CC view include an adequate 
portion of the inner region of the breast [13]. However, breast cancer mostly appears in 
area C [14]. Therefore, it is necessary to depict both the inside and outside of the CC view.  
Therefore, it can be concluded that the best time for CC image acquisition is during 
Phase III, the late follicular phase. In Phase III, the mammary gland is thinnest and most 
compressible, and pain is at its lowest. Acquiring the mammographic images while paying 




There are several limitations to our study. First, the number of participants was small. 
Second, the participants were all in their twenties. Third, only one radiological 
technologist performed the positioning for mammography. Further study is needed with 
a larger sample size with a wider age distribution. Moreover, it is necessary to investigate 




In the CC view, pain was maximum during Phase I and minimal during Phase III. 
Correspondingly, the thickness and volume of the mammary gland were maximum during 
Phase I and minimal during Phase III. The changes in the upper mammary gland greatly 
contributed to these results. Phase III, the late follicular phase, is the most appropriate 
phase for mammography. If it is not possible to perform mammography during Phase III, 
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Table 1: Classification of the menstrual cycle 
 
Phase Period 
I Late luteal and early follicular phase, from 3 days before menstruation to menstruation day 3 
Ⅱ Middle follicular phase, from day 4 to the last day of menstruation 
Ⅲ Late follicular phase, from the next day after the end of menstruation to the day before 
ovulation 
Ⅳ Ovulatory and early luteal phase, from the day of ovulation until 4 days later 













Table2: Mammary gland thickness in each menstrual phase (mm) 
 
 Phase
Ⅰ Ⅱ Ⅲ Ⅳ Ⅴ 
Inside 31.00 ± 8.39 29.31 ± 8.88
28.37 ± 
8.20 29.09 ± 8.38 
30.77 ± 
8.68 
Outside 31.59 ± 8.71 30.43 ± 8.32
29.11 ± 
8.53 29.78 ± 8.98 
31.64 ± 
9.38 















Table3: Mammary gland thickness in each menstrual phase (mm3) 
 
 Phase 
Ⅰ Ⅱ Ⅲ Ⅳ Ⅴ 


















































Data are expressed as mean values ± standard deviations. 
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Figure legends 
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